Home › Trial NCT07495124
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
- Trial IDNCT07495124
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of Washington
- Enrollment26
- Start date2026-09-16
- ConditionsFallopian Tube Carcinoma · Ovarian Carcinoma · Primary Peritoneal Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.